293 related articles for article (PubMed ID: 5392781)
41. Radioactive iodine therapy for progressive malignant exophthalmos.
Bauer FK; Catz B
Acta Endocrinol (Copenh); 1966 Jan; 51(1):14-22. PubMed ID: 5951904
[No Abstract] [Full Text] [Related]
42. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
Valenta L; Lemarchand-Béraud T; Vannotti A
Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
[No Abstract] [Full Text] [Related]
43. The interaction between thyroid tissue and the long-acting thyroid stimulator.
Kendall-Taylor P; Smith BR; Munro DS
Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
[No Abstract] [Full Text] [Related]
44. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
[No Abstract] [Full Text] [Related]
45. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
46. [Long-acting thyroid stimulator (LATS) as the cause of hyperthyroidism. Comparison of different TSH and LATS preparations].
Seif F
Dtsch Med Wochenschr; 1967 Jan; 92(4):147-52. PubMed ID: 6016320
[No Abstract] [Full Text] [Related]
47. L.A.T.S. and Graves' disease.
Hedley AJ; Ross IP; Crooks J
Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
[No Abstract] [Full Text] [Related]
48. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
[No Abstract] [Full Text] [Related]
49. Influence of the long-acting thyroid stimulator (LATS) on radioiodine-labelled thyroxine and triiodothyronine in the thyroid of mice.
Emrich D; von Toll-Jürgens KH; zur Mühlen A Von
Endocrinology; 1970 Sep; 87(3):632-6. PubMed ID: 5424582
[No Abstract] [Full Text] [Related]
50. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
Werner SC; Feind CR; Aida M
N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
[No Abstract] [Full Text] [Related]
51. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
52. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
[No Abstract] [Full Text] [Related]
53. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
54. Studies on the pathogenesis of the ophthalmopathy of Graves' disease.
Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R
J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430
[No Abstract] [Full Text] [Related]
55. PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.
MOSIER HD
J Clin Endocrinol Metab; 1965 Aug; 25():1005-8. PubMed ID: 14328369
[No Abstract] [Full Text] [Related]
56. [Significance of the "long acting thyroid stimulator"].
Tourneur R; Letonturier P; Sénécal P
Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
[No Abstract] [Full Text] [Related]
57. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
Onaya T; Kotani M; Yamada T; Ochi Y
J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
[No Abstract] [Full Text] [Related]
58. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
Studer H
Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
[No Abstract] [Full Text] [Related]
59. [Chronic thrombopenic purpura. Hyperthyroidism, pretibial myxedema and L.A.T.S].
Cattan D; Caen J; Fernandez Y; Izard J; Leclere H; Tanguy A; Lemenager J
Presse Med (1893); 1970 Jul; 78(35):1535-40. PubMed ID: 5464336
[No Abstract] [Full Text] [Related]
60. Epidemiology and pathogenesis of iodine-induced thyrotoxicosis in Northern Tasmania.
Stewart JC
N Z Med J; 1975 Jan; 81(531):25-6. PubMed ID: 1055312
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
